Cronos (CRON) Share-based Compensation (2019 - 2026)
Cronos (CRON) posted quarterly Share-based Compensation of $1.3 million for Q1 2026, down 55.19% year-over-year from $2.9 million in Q1 2025, and up 119.57% quarter-over-quarter from $598000.0 in Q4 2025.
Cronos (CRON) Share-based Compensation (2019 - 2026) Analysis & Trends
Cronos' Share-based Compensation history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 55.19% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $2.1 million (down 0.56% YoY), while the FY2025 annual figure was $3.8 million, up 204.71% from the prior year.
- Share-based Compensation for Q1 2026 stood at $1.3 million, up from $598000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $8.5 million in Q3 2022, with the low at -$7.7 million in Q4 2022.
- The 5-year median for Share-based Compensation is $1.3 million (2026), against an average of $597294.1.
- Peak annual rise in Share-based Compensation reached 528.46% in 2022, while the deepest fall reached 155.3% in 2022.
- Cronos' Share-based Compensation stood at -$7.7 million in 2022, then gained by 24.92% to -$5.8 million in 2023, then grew by 9.09% to -$5.3 million in 2024, then soared by 111.32% to $598000.0 in 2025, then soared by 119.57% to $1.3 million in 2026.
- Business Quant data shows CRON's Share-based Compensation at $1.3 million in Q1 2026, $598000.0 in Q4 2025, and -$316000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 598,000.00 |
| Dec 31, 2025 | 598,000.00 |
| Sep 30, 2025 | -316,000.00 |
| Sep 30, 2025 | -316,000.00 |
| Jun 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 539,000.00 |
| Mar 31, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | -5.28 Mn |
| Dec 31, 2024 | -5.28 Mn |
| Sep 30, 2024 | 5.61 Mn |
| Sep 30, 2024 | 5.61 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |